A Weekly Injection Could Replace Painful Daily Treatment for Rare Fat Disorder
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
Keep An Eye On EYPT - Diabetic Macular Edema, Wet AMD Trial Results Awaited
EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...
WebMD2y
Understanding Insulin Injections
When it comes to type 2 diabetes, using injectables can be the most effective way to balance blood sugar levels. Understanding both the benefits and the side effects of injectables will promote a ...
Medscape19d
The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy
Diabetes. 2005;54(7):2188-2197.
FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
WebMD1y
Why Prescribe an Injectable?
Patients with type 2 diabetes have a component of insulin resistance ... Understandably, no one likes the idea of taking an injection. However, newer forms of syringes and pens have made ...
Hosted on MSN1mon
Hong Kong could be first to get Swiss start-up’s drug for diabetic eye disease
Oculis' OCS-01 eye drops, currently in phase 3 trials for diabetic ... adhere to the injection-treatment regime and respond well, they can only regain half their lost visual acuity.